{
  "nctId": "NCT05554042",
  "briefTitle": "Kintsugi Voice Device Study",
  "officialTitle": "Kintsugi Voice Device Study",
  "protocolDocument": {
    "nctId": "NCT05554042",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2022-09-07",
    "uploadDate": "2022-09-27T10:23",
    "size": 350425,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT05554042/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "OBSERVATIONAL",
  "enrollmentInfo": {
    "enrollmentCount": 132,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2022-09-23",
    "completionDate": "2023-07-05",
    "primaryCompletionDate": "2023-07-05",
    "firstSubmitDate": "2022-09-21",
    "firstPostDate": "2022-09-26"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Subjects greater than or equal to 22 years of age at the time of informed consent\n* Participants must be able to read, understand, and sign the Informed Consent Form\n* Access to a laptop, smartphone, tablet, or other Device with a functioning microphone\n* Participants must be willing to be videotaped as part of the study\n* Stated willingness to comply with all study procedures and availability for the duration of the study\n* Fluency in English\n* Availability for the duration of the study\n* The participant must reside within the state of California\n\nExclusion Criteria:\n\n* Any impairment that would prevent participants from completing an online survey and/or engage in clinician assessment interviews (e.g., visual impairment, motor impairment, hearing impairment, acute intoxication)\n* Any known history of neurodegenerative or Central Nervous System disorders\n* Any known history of schizophrenia, psychosis, or severe cognitive deficits\n* Any known presence of disorders that may lead to false signal of depression or anxiety including Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Parkinson's Disease, Stroke, Traumatic Brain Injury\n* Presence of voice disorders that may impact vocal cords such as acute or chronic laryngitis, vocal cord paresis or paralysis, or spasmodic dysphonia\n* Any known history of vocal cord injury or cerebrovascular accident or head trauma with residual dysarthria in the past year\n* Past or active heavy smokers if there is impact on the vocal cords\n* Any known history of congenital deafness\n* Subjects who do not speak English\n* Subjects who do not live in the United States\n* Subjects who have previously participated in any Kintsugi-sponsored study",
    "healthyVolunteers": true,
    "sex": "ALL",
    "minimumAge": "22 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Sensitivity and Specificity of the Kintsugi Voice Device for a Significant Depressive Episode",
        "description": "Discriminates the presence of a significant depressive episode using the Structure Clinical Interview for the Diagnostic Statistical Manual for Mental Disorders-5 as the ground truth, diagnostic standard",
        "timeFrame": "Through study completion, on average 2 weeks"
      },
      {
        "measure": "Sensitivity and Specificity of the Kintsugi Voice Device for a Significant Anxiety State",
        "description": "Discriminates the presence of a significant anxiety state using the Structure Clinical Interview for the Diagnostic Statistical Manual for Mental Disorders-5 as the ground truth, diagnostic standard",
        "timeFrame": "Through study completion, on average 2 weeks"
      }
    ],
    "secondary": [
      {
        "measure": "Proportion of Indeterminate Outputs",
        "description": "Measure the proportion of participants who complete the study and the device output is Indeterminate.",
        "timeFrame": "Through study completion, on average 2 weeks."
      },
      {
        "measure": "Sensitivity and Specificity of the Kintsugi Voice Device with Patient Health Questionnaire-9 Ground Truth",
        "description": "Discriminating the presence of a significant depressive episode against the Patient Health Questionnaire-9 as the ground truth.",
        "timeFrame": "Through study completion, on average 2 weeks"
      },
      {
        "measure": "Sensitivity and Specificity of the Kintsugi Voice Device with Generalized Anxiety Disorder-7 Ground Truth",
        "description": "Discriminating the presence of a significant anxiety state against the Generalized Anxiety Disorder-7 as the ground truth.",
        "timeFrame": "Through study completion, on average 2 weeks"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 2,
      "secondaryCount": 3,
      "otherCount": 0,
      "totalCount": 5
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 54,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-21T22:34:02.570Z",
  "dataSource": "ClinicalTrials.gov API v2 - Mass Collection"
}